Kaur, G.; Jain, R.; Grover, P.; Yasin, Z.; Singh, K.; Singh, B.
Systematic Review of Malignancy Risk with Biologic, Advanced Small-Molecule, and Thiopurine Therapies for Inflammatory Bowel Disease. Gastrointest. Disord. 2026, 8, 38.
https://doi.org/10.3390/gidisord8030038
AMA Style
Kaur G, Jain R, Grover P, Yasin Z, Singh K, Singh B.
Systematic Review of Malignancy Risk with Biologic, Advanced Small-Molecule, and Thiopurine Therapies for Inflammatory Bowel Disease. Gastrointestinal Disorders. 2026; 8(3):38.
https://doi.org/10.3390/gidisord8030038
Chicago/Turabian Style
Kaur, Gurleen, Rahul Jain, Palak Grover, Zarqa Yasin, Karanbir Singh, and Bipneet Singh.
2026. "Systematic Review of Malignancy Risk with Biologic, Advanced Small-Molecule, and Thiopurine Therapies for Inflammatory Bowel Disease" Gastrointestinal Disorders 8, no. 3: 38.
https://doi.org/10.3390/gidisord8030038
APA Style
Kaur, G., Jain, R., Grover, P., Yasin, Z., Singh, K., & Singh, B.
(2026). Systematic Review of Malignancy Risk with Biologic, Advanced Small-Molecule, and Thiopurine Therapies for Inflammatory Bowel Disease. Gastrointestinal Disorders, 8(3), 38.
https://doi.org/10.3390/gidisord8030038